COSTANTINI, Susan
 Distribuzione geografica
Continente #
NA - Nord America 169
EU - Europa 132
AS - Asia 64
SA - Sud America 4
Totale 369
Nazione #
US - Stati Uniti d'America 169
IE - Irlanda 54
CN - Cina 25
UA - Ucraina 20
SG - Singapore 18
HK - Hong Kong 16
DE - Germania 15
GB - Regno Unito 14
IT - Italia 11
GR - Grecia 6
FI - Finlandia 5
TR - Turchia 5
BR - Brasile 4
BE - Belgio 3
SE - Svezia 2
BA - Bosnia-Erzegovina 1
FR - Francia 1
Totale 369
Città #
Dublin 54
Chandler 47
Jacksonville 29
Santa Clara 24
Hong Kong 16
Singapore 10
Beijing 6
Bremen 6
Medford 6
Princeton 6
Roxbury 5
Nanjing 4
Brussels 3
Caserta 3
Wilmington 3
Ann Arbor 2
Ashburn 2
Boardman 2
Falls Church 2
Guangzhou 2
Munich 2
New York 2
Newark 2
Tianjin 2
Zhengzhou 2
Changsha 1
Criciúma 1
Curitiba 1
Des Moines 1
Düsseldorf 1
Fuzhou 1
Helsinki 1
Jinan 1
London 1
Napoli 1
San Giorgio Del Sannio 1
San Mateo 1
Seattle 1
Shenyang 1
São Paulo 1
Teslić 1
The Dalles 1
Vasylkiv 1
Votuporanga 1
Totale 261
Nome #
The Cytokinome Profile in Patients with Hepatocellular Carcinoma and Type 2 Diabetes 73
Characterization and kinetics studies of water buffalo (Bubalus bubalis) myoglobin 71
Correction: Metabolomic profiling and biochemical evaluation of the follicular fluid of endometriosis patients (Molecular BioSystems (2017) DOI: 10.1039/c7mb00181a) 69
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 62
Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients 56
GPX4 and GPX7 over-expression in human hepatocellular carcinoma tissues 55
Totale 386
Categoria #
all - tutte 1.815
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.815


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 0 0 1 0
2020/202143 5 0 4 2 10 0 6 4 3 2 7 0
2021/202238 1 0 0 0 15 5 0 0 2 2 2 11
2022/2023128 10 2 6 13 14 14 0 10 55 1 2 1
2023/202435 2 2 4 1 9 2 0 3 0 0 3 9
2024/202573 0 1 0 3 20 18 8 6 10 7 0 0
Totale 386